If you need additional information, please visit ASES website through the ASES button
![](/wp-content/uploads/2024/01/HEADER-1.png)
![](/wp-content/uploads/2024/01/SLIDER-11-1.png)
![](/wp-content/uploads/2024/01/SLIDER-1-1.png)
![](/wp-content/uploads/2024/01/SLIDER-2-1.png)
![](/wp-content/uploads/2024/01/SLIDER-3-1.png)
![](/wp-content/uploads/2024/01/SLIDER-4-1.png)
![](/wp-content/uploads/2024/01/SLIDER-5-1.png)
![](/wp-content/uploads/2024/01/SLIDER-6-1.png)
![](/wp-content/uploads/2024/01/SLIDER-7-1.png)
![](/wp-content/uploads/2024/01/SLIDER-8-1.png)
![](/wp-content/uploads/2024/01/SLIDER-9-1.png)
![](/wp-content/uploads/2024/01/SLIDER-10.png)
![](/wp-content/uploads/2024/01/SLIDER-12-1.png)
![](/wp-content/uploads/2024/01/SLIDER-13-1.png)
Providers
- Your Primary Care Physician and other doctors
- How can I see my PCP?
- What if it’s an emergency and I need care after my PCP’s office closes?
- Can I change my PCP?
- What happens after I ask for the change?
- What about other doctors or providers I need to see?
- Help with getting to your health care visits
- Provider Directory
Releases
- Communication regarding Circular Letter 20-0930
- Communication regarding Circular Letter 20-0930
- Communication regarding Circular Letter 20-0930
- Communication regarding Circular Letter 20-0930
- Communication regarding Circular Letter 20-0826-02
- Communication regarding Circular Letter 20-0826-02
- Communication regarding Circular Letter 20-0826-02
- Communication regarding Circular Letter 20-0826-02
- Communication regarding Normative Letter 20-03-16A Amended
- Communication regarding Normative Letter 20-03-16A Amended
- Communication regarding Normative Letter 20-03-16A Amended
- Communication regarding Normative Letter 20-03-16A Amended
- Communication regarding Normative Letter 20-0404 A
- Communication regarding Normative Letter 20-0404 A
- Communication regarding Normative Letter 20-0404 A
- Communication regarding Normative Letter 20-0404 A
- Communication regarding Normative Letter No. 20-0825
- Communication regarding Normative Letter No. 20-0825
- Communication regarding Normative Letter No. 20-0825
- Communication regarding Normative Letter No. 20-0825
- Communication regarding Normative Letter No. 20-0824
- Communication regarding Normative Letter No. 20-0824
- Communication regarding Normative Letter No. 20-0824
- Communication regarding Normative Letter No. 20-0824
- Communication regarding Normative Letter No. 20-0819
- Communication regarding Normative Letter No. 20-0819
- Communication regarding Normative Letter No. 20-0819
- Communication regarding Normative Letter No. 20-0819
- Communication regarding Provider Enrollment Portal (PEP)
- Communication regarding Provider Enrollment Portal (PEP)
- Communication regarding Provider Enrollment Portal (PEP)
- Communication regarding Provider Enrollment Portal (PEP)
- Communication regarding Circular Letter No. 20-0630
- Communication regarding Circular Letter No. 20-0630
- Communication regarding Circular Letter No. 20-0630
- Communication regarding Circular Letter No. 20-0630
- Communication regarding Circular Letter 20-0806
- Communication regarding Circular Letter 20-0806
- Communication regarding Circular Letter 20-0806
- Communication regarding Circular Letter 20-0806
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 7
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 7
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 7
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 7
- Communication regarding Normative Letter 20-0717
- Communication regarding Normative Letter 20-0717
- Communication regarding Normative Letter 20-0717
- Communication regarding Normative Letter 20-0717
- Clinical Practice Guidelines 2020
- Clinical Practice Guidelines 2020
- Clinical Practice Guidelines 2020
- Clinical Practice Guidelines 2020
- Communication regarding Circular Letter No. 20-0713
- Communication regarding Circular Letter No. 20-0713
- Communication regarding Circular Letter No. 20-0713
- Communication regarding Circular Letter No. 20-0713
- Communication regarding Circular Letter 20-0713-01
- Communication regarding Circular Letter 20-0713-01
- Communication regarding Circular Letter 20-0713-01
- Communication regarding Circular Letter 20-0713-01
- Communication regarding Normative Letter 20-03-18 Amended
- Communication regarding Normative Letter 20-03-18 Amended
- Communication regarding Normative Letter 20-03-18 Amended
- Communication regarding Normative Letter 20-03-18 Amended
- Communication regarding Normative Letter 20-03-16B Amended
- Communication regarding Normative Letter 20-03-16B Amended
- Communication regarding Normative Letter 20-03-16B Amended
- Communication regarding Normative Letter 20-03-16B Amended
- Communication regarding Normative Letter 20-05-01A
- Communication regarding Normative Letter 20-05-01A
- Communication regarding Normative Letter 20-05-01A
- Communication regarding Normative Letter 20-05-01A
- Communication regarding Circular Letter 20-0603-01
- Communication regarding Circular Letter 20-0603-01
- Communication regarding Circular Letter 20-0603-01
- Communication regarding Circular Letter 20-0603-01
- Communication regarding Circular Letter 20-0619
- Communication regarding Circular Letter 20-0619
- Communication regarding Circular Letter 20-0619
- Communication regarding Circular Letter 20-0619
- Communication regarding Normative Letter 20-0616-01
- Communication regarding Normative Letter 20-0616-01
- Communication regarding Normative Letter 20-0616-01
- Communication regarding Normative Letter 20-0616-01
- Communication regarding Normative Letter 20-0612
- Communication regarding Normative Letter 20-0612
- Communication regarding Normative Letter 20-0612
- Communication regarding Normative Letter 20-0612
- Communication regarding Normative Letter 20-0611
- Communication regarding Normative Letter 20-0611
- Communication regarding Normative Letter 20-0611
- Communication regarding Normative Letter 20-0611
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 5
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 5
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 5
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal – Wave 5
- Communication regarding Normative Letter 20-0527
- Communication regarding Normative Letter 20-0527
- Communication regarding Normative Letter 20-0527
- Communication regarding Normative Letter 20-0527
- Communication regarding Normative Letter 20-0601
- Communication regarding Normative Letter 20-0601
- Communication regarding Normative Letter 20-0601
- Communication regarding Normative Letter 20-0601
- Communication regarding Normative Letter 20-0529
- Communication regarding Normative Letter 20-0529
- Communication regarding Normative Letter 20-0529
- Communication regarding Normative Letter 20-0529
- Communication regarding Normative Letter 20-05-01
- Communication regarding Normative Letter 20-05-01
- Communication regarding Normative Letter 20-05-01
- Communication regarding Normative Letter 20-05-01
- Communication regarding Normative Letter 20-0519
- Communication regarding Normative Letter 20-0519
- Communication regarding Normative Letter 20-0519
- Communication regarding Normative Letter 20-0519
- Communication regarding Administrative Order No. 442
- Communication regarding Administrative Order No. 442
- Communication regarding Administrative Order No. 442
- Communication regarding Administrative Order No. 442
- Communication regarding Executive Order 2020-036
- Communication regarding Executive Order 2020-036
- Communication regarding Executive Order 2020-036
- Communication regarding Executive Order 2020-036
- Communication regarding Normative Letter 20-0514
- Communication regarding Normative Letter 20-0514
- Communication regarding Normative Letter 20-0514
- Communication regarding Normative Letter 20-0514
- Communication regarding Administrative Order 424
- Communication regarding Administrative Order 424
- Communication regarding Administrative Order 424
- Communication regarding Administrative Order 424
- Communication regarding Normative Letter 20-0427
- Communication regarding Normative Letter 20-0427
- Communication regarding Normative Letter 20-0427
- Communication regarding Normative Letter 20-0427
- Communication regarding Normative Letter 20-0423
- Communication regarding Normative Letter 20-0423
- Communication regarding Normative Letter 20-0423
- Communication regarding Normative Letter 20-0423
- Communication regarding Normative Letter 20-04-01A
- Communication regarding Normative Letter 20-04-01A
- Communication regarding Normative Letter 20-04-01A
- Communication regarding Normative Letter 20-04-01A
- Communication regarding Normative Letter 20-0421
- Communication regarding Normative Letter 20-0421
- Communication regarding Normative Letter 20-0421
- Communication regarding Normative Letter 20-0421
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0420
- Communication regarding Normative Letter 20-0420
- Communication regarding Normative Letter 20-0420
- Communication regarding Normative Letter 20-0420
- Communication regarding Normative Letter 19-0826 A
- Communication regarding Normative Letter 19-0826 A
- Communication regarding Normative Letter 19-0826 A
- Communication regarding Normative Letter 19-0826 A
- Communication regarding Normative Letter 20-0402A related to Teledentistry
- Communication regarding Normative Letter 20-0402A related to Teledentistry
- Communication regarding Normative Letter 20-0402A related to Teledentistry
- Communication regarding Normative Letter 20-0402A related to Teledentistry
- Communication regarding Normative Letter 20-04-02 related to Teledentistry
- Communication regarding Normative Letter 20-04-02 related to Teledentistry
- Communication regarding Normative Letter 20-04-02 related to Teledentistry
- Communication regarding Normative Letter 20-04-02 related to Teledentistry
- Communication regarding Normative Letter 20-04-01 related to Coverage and Benefits for COVID-19
- Communication regarding Normative Letter 20-04-01 related to Coverage and Benefits for COVID-19
- Communication regarding Normative Letter 20-04-01 related to Coverage and Benefits for COVID-19
- Communication regarding Normative Letter 20-04-01 related to Coverage and Benefits for COVID-19
- Communication regarding Normative Letter 20-0320
- Communication regarding Normative Letter 20-0320
- Communication regarding Normative Letter 20-0320
- Communication regarding Normative Letter 20-0320
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Normative Letter 20-0326
- Communication regarding Administrative Order Number 426
- Communication regarding Administrative Order Number 426
- Communication regarding Administrative Order Number 426
- Communication regarding Administrative Order Number 426
- Communication regarding Normative Letter 20-0318-A
- Communication regarding Normative Letter 20-0318-A
- Communication regarding Normative Letter 20-0318-A
- Communication regarding Normative Letter 20-0318-A
- Communication regarding Normative Letter 20-0318
- Communication regarding Normative Letter 20-0318
- Communication regarding Normative Letter 20-0318
- Communication regarding Normative Letter 20-0318
- Communication regarding Normative Letter 20-03-17
- Communication regarding Normative Letter 20-03-17
- Communication regarding Normative Letter 20-03-17
- Communication regarding Normative Letter 20-03-17
- Communication regarding Normative Letter 20-03-16B
- Communication regarding Normative Letter 20-03-16B
- Communication regarding Normative Letter 20-03-16B
- Communication regarding Normative Letter 20-03-16B
- Communication regarding Normative Letter 20-03-16A
- Communication regarding Normative Letter 20-03-16A
- Communication regarding Normative Letter 20-03-16A
- Communication regarding Normative Letter 20-03-16A
- Communication regarding Normative Letter 20-0313 related to Changes in the Pharmacy Benefit due to COVID-19
- Communication regarding Normative Letter 20-0313 related to Changes in the Pharmacy Benefit due to COVID-19
- Communication regarding Normative Letter 20-0313 related to Changes in the Pharmacy Benefit due to COVID-19
- Communication regarding Normative Letter 20-0313 related to Changes in the Pharmacy Benefit due to COVID-19
- Communication regarding Normative Letter 20-0311 Coverage and Benefits related to COVID-19
- Communication regarding Normative Letter 20-0311 Coverage and Benefits related to COVID-19
- Communication regarding Normative Letter 20-0311 Coverage and Benefits related to COVID-19
- Communication regarding Normative Letter 20-0311 Coverage and Benefits related to COVID-19
- Communication regarding Informative Letter related to Kmart Pharmacies Closure
- Communication regarding Informative Letter related to Kmart Pharmacies Closure
- Communication regarding Informative Letter related to Kmart Pharmacies Closure
- Communication regarding Informative Letter related to Kmart Pharmacies Closure
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal
- Communication regarding Puerto Rico Medicaid Program Provider Enrollment Portal
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Caries Risk Assessment Form
- Caries Risk Assessment Form
- Caries Risk Assessment Form
- Caries Risk Assessment Form
- Communication regarding Normative Letter Number 19-1104 related to the Referral and/or Consultant Form and the Vital Plan Priorauthorization Form.
- Communication regarding Normative Letter Number 19-1104 related to the Referral and/or Consultant Form and the Vital Plan Priorauthorization Form.
- Communication regarding Normative Letter Number 19-1104 related to the Referral and/or Consultant Form and the Vital Plan Priorauthorization Form.
- Communication regarding Normative Letter Number 19-1104 related to the Referral and/or Consultant Form and the Vital Plan Priorauthorization Form.
- Communication regarding Puerto Rico Medicaid Program Provider Portal
- Communication regarding Puerto Rico Medicaid Program Provider Portal
- Communication regarding Puerto Rico Medicaid Program Provider Portal
- Communication regarding Puerto Rico Medicaid Program Provider Portal
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Circular Letter related to Kmart Pharmacies Closure
- Communication regarding Normative Letter Number 19-1023 related to Change in the Edit of the Infusion Supply for Insulin Pumps
- Communication regarding Normative Letter Number 19-1023 related to Change in the Edit of the Infusion Supply for Insulin Pumps
- Communication regarding Normative Letter Number 19-1023 related to Change in the Edit of the Infusion Supply for Insulin Pumps
- Communication regarding Normative Letter Number 19-1023 related to Change in the Edit of the Infusion Supply for Insulin Pumps
- Communication regarding Normative Letter Number 19-1022 related to the PRHIA Policy on Hearing Loss and Diagnosis
- Communication regarding Normative Letter Number 19-1022 related to the PRHIA Policy on Hearing Loss and Diagnosis
- Communication regarding Normative Letter Number 19-1022 related to the PRHIA Policy on Hearing Loss and Diagnosis
- Communication regarding Normative Letter Number 19-1022 related to the PRHIA Policy on Hearing Loss and Diagnosis
- Provider Guidelines
- Provider Guidelines
- Provider Guidelines
- Provider Guidelines
- Special Autism Coverage Informative Letter
- Special Autism Coverage Informative Letter
- Special Autism Coverage Informative Letter
- Special Autism Coverage Informative Letter
- Communication regarding Normative Letter Number 18-0705-A, related to the Updated Pediatric Preventive Practice Guideline
- Communication regarding Normative Letter Number 18-0705-A, related to the Updated Pediatric Preventive Practice Guideline
- Communication regarding Normative Letter Number 18-0705-A, related to the Updated Pediatric Preventive Practice Guideline
- Communication regarding Normative Letter Number 18-0705-A, related to the Updated Pediatric Preventive Practice Guideline
- Diabetes Informative Letter- Act No. 177 of 2016
- Diabetes Informative Letter- Act No. 177 of 2016
- Diabetes Informative Letter- Act No. 177 of 2016
- Diabetes Informative Letter- Act No. 177 of 2016
- Bulletin- Materials for Vital Plan Enrollees
- Bulletin- Materials for Vital Plan Enrollees
- Bulletin- Materials for Vital Plan Enrollees
- Bulletin- Materials for Vital Plan Enrollees
- Communication regarding Normative Letter 2019-10-02- Dental Fee Schedule
- Communication regarding Normative Letter 2019-10-02- Dental Fee Schedule
- Communication regarding Normative Letter 2019-10-02- Dental Fee Schedule
- Communication regarding Normative Letter 2019-10-02- Dental Fee Schedule
- Recommendations for the Feeding of Healthy Children from 0 to 24 months
- Recommendations for the Feeding of Healthy Children from 0 to 24 months
- Recommendations for the Feeding of Healthy Children from 0 to 24 months
- Recommendations for the Feeding of Healthy Children from 0 to 24 months
- Communication regarding Suspension of Administrative Order 19-0923
- Communication regarding Suspension of Administrative Order 19-0923
- Communication regarding Suspension of Administrative Order 19-0923
- Communication regarding Suspension of Administrative Order 19-0923
- Communication regarding Administrative Order Number 19-0923 related to ASES’ Policy for Vital Plan Beneficiaries: Medication Management During and After the Pass of Karen Storm.
- Communication regarding Administrative Order Number 19-0923 related to ASES’ Policy for Vital Plan Beneficiaries: Medication Management During and After the Pass of Karen Storm.
- Communication regarding Administrative Order Number 19-0923 related to ASES’ Policy for Vital Plan Beneficiaries: Medication Management During and After the Pass of Karen Storm.
- Communication regarding Administrative Order Number 19-0923 related to ASES’ Policy for Vital Plan Beneficiaries: Medication Management During and After the Pass of Karen Storm.
- Communication regarding Normative Letter Number 19-0919 related to the Interferon-Gamma Release Assays (IGRAs) test
- Communication regarding Normative Letter Number 19-0919 related to the Interferon-Gamma Release Assays (IGRAs) test
- Communication regarding Normative Letter Number 19-0919 related to the Interferon-Gamma Release Assays (IGRAs) test
- Communication regarding Normative Letter Number 19-0919 related to the Interferon-Gamma Release Assays (IGRAs) test
- Communication regarding Circular Letter CC-2019-1953-D related to Cancer Chemotherapy Treatments
- Communication regarding Circular Letter CC-2019-1953-D related to Cancer Chemotherapy Treatments
- Communication regarding Circular Letter CC-2019-1953-D related to Cancer Chemotherapy Treatments
- Communication regarding Circular Letter CC-2019-1953-D related to Cancer Chemotherapy Treatments
- Communication regarding Normative Letter Number 19-0904 related to Changes in the Albuterol Coverage
- Communication regarding Normative Letter Number 19-0904 related to Changes in the Albuterol Coverage
- Communication regarding Normative Letter Number 19-0904 related to Changes in the Albuterol Coverage
- Communication regarding Normative Letter Number 19-0904 related to Changes in the Albuterol Coverage
- Communication regarding Suspension of Administrative Orders 19-0827 and 19-0827B
- Communication regarding Suspension of Administrative Orders 19-0827 and 19-0827B
- Communication regarding Suspension of Administrative Orders 19-0827 and 19-0827B
- Communication regarding Suspension of Administrative Orders 19-0827 and 19-0827B
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Medical and Hospital Services During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Medical and Hospital Services During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Medical and Hospital Services During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Medical and Hospital Services During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Drug Management During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Drug Management During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Drug Management During and After the Pass of Dorian Storm
- Communication regarding Administrative Order Number 19-0827 related to ASES’ Policy for Vital Plan Beneficiaries: Drug Management During and After the Pass of Dorian Storm
- Communication regarding Normative Letter Number 19-0826, Amended related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0826, Amended related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0826, Amended related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0826, Amended related to Changes in the Covered Drug Formulary
- Preventive Care Service Guideline 2019
- Preventive Care Service Guideline 2019
- Preventive Care Service Guideline 2019
- Preventive Care Service Guideline 2019
- Communication regarding Normative Letter Number 19-0726 related to Vaccination
- Communication regarding Normative Letter Number 19-0726 related to Vaccination
- Communication regarding Normative Letter Number 19-0726 related to Vaccination
- Communication regarding Normative Letter Number 19-0726 related to Vaccination
- Communication regarding Normative Letter Number 19-0724A related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0724A related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0724A related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0724A related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter 19-0627 related to Covered of Suboxone® SL FILM generic version
- Communication regarding Normative Letter 19-0627 related to Covered of Suboxone® SL FILM generic version
- Communication regarding Normative Letter 19-0627 related to Covered of Suboxone® SL FILM generic version
- Communication regarding Normative Letter 19-0627 related to Covered of Suboxone® SL FILM generic version
- Communication regarding Normative Letter 19-0706 related to Covered Changes on Suboxone® SL FILM
- Communication regarding Normative Letter 19-0706 related to Covered Changes on Suboxone® SL FILM
- Communication regarding Normative Letter 19-0706 related to Covered Changes on Suboxone® SL FILM
- Communication regarding Normative Letter 19-0706 related to Covered Changes on Suboxone® SL FILM
- Communication regarding Circular Letter 19-0530 related to the Education on the Authorized Generics Management
- Communication regarding Circular Letter 19-0530 related to the Education on the Authorized Generics Management
- Communication regarding Circular Letter 19-0530 related to the Education on the Authorized Generics Management
- Communication regarding Circular Letter 19-0530 related to the Education on the Authorized Generics Management
- Clinical Practice Guidelines Notification
- Clinical Practice Guidelines Notification
- Clinical Practice Guidelines Notification
- Clinical Practice Guidelines Notification
- Puerto Rico Asthma Program Informative Bulletin
- Puerto Rico Asthma Program Informative Bulletin
- Puerto Rico Asthma Program Informative Bulletin
- Puerto Rico Asthma Program Informative Bulletin
- Communication regarding Normative Letter Number 19-0424 related to Standardized Prior-authorization Form
- Communication regarding Normative Letter Number 19-0424 related to Standardized Prior-authorization Form
- Communication regarding Normative Letter Number 19-0424 related to Standardized Prior-authorization Form
- Communication regarding Normative Letter Number 19-0424 related to Standardized Prior-authorization Form
- Communication related to Physician Registry in PDMP recommended for the Vital Plan Providers
- Communication related to Physician Registry in PDMP recommended for the Vital Plan Providers
- Communication related to Physician Registry in PDMP recommended for the Vital Plan Providers
- Communication related to Physician Registry in PDMP recommended for the Vital Plan Providers
- Communication regarding Normative Letter Number 19-0417 related to Contraceptive Coverage for the reproductive age population of the Vital Plan
- Communication regarding Normative Letter Number 19-0417 related to Contraceptive Coverage for the reproductive age population of the Vital Plan
- Communication regarding Normative Letter Number 19-0417 related to Contraceptive Coverage for the reproductive age population of the Vital Plan
- Communication regarding Normative Letter Number 19-0417 related to Contraceptive Coverage for the reproductive age population of the Vital Plan
- Communication regarding Normative Letter Number 19-0305-Amended related to Public Policy Anti-discrimination to beneficiaries
- Communication regarding Normative Letter Number 19-0305-Amended related to Public Policy Anti-discrimination to beneficiaries
- Communication regarding Normative Letter Number 19-0305-Amended related to Public Policy Anti-discrimination to beneficiaries
- Communication regarding Normative Letter Number 19-0305-Amended related to Public Policy Anti-discrimination to beneficiaries
- Communication regarding Normative Letter Number 19-0402 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0402 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0402 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0402 related to Changes in the Covered Drug Formulary
- Informative Letter regarding Vital-X Population
- Informative Letter regarding Vital-X Population
- Informative Letter regarding Vital-X Population
- Informative Letter regarding Vital-X Population
- Communication regarding Normative Letter Number 15-1002-C related to Contraceptive Coverage for the Vital Plan reproductive age population.
- Communication regarding Normative Letter Number 15-1002-C related to Contraceptive Coverage for the Vital Plan reproductive age population.
- Communication regarding Normative Letter Number 15-1002-C related to Contraceptive Coverage for the Vital Plan reproductive age population.
- Communication regarding Normative Letter Number 15-1002-C related to Contraceptive Coverage for the Vital Plan reproductive age population.
- Communication regarding Normative Letter Number 2019-0320 related to Billing Code for the Trogarzo® Administration.
- Communication regarding Normative Letter Number 2019-0320 related to Billing Code for the Trogarzo® Administration.
- Communication regarding Normative Letter Number 2019-0320 related to Billing Code for the Trogarzo® Administration.
- Communication regarding Normative Letter Number 2019-0320 related to Billing Code for the Trogarzo® Administration.
- Communication regarding Administrative Order 402 related to Naloxona Medication
- Communication regarding Administrative Order 402 related to Naloxona Medication
- Communication regarding Administrative Order 402 related to Naloxona Medication
- Communication regarding Administrative Order 402 related to Naloxona Medication
- Communication regarding Normative Letter Number 19-0116-Amended related to Medications for Hepatitis C.
- Communication regarding Normative Letter Number 19-0116-Amended related to Medications for Hepatitis C.
- Communication regarding Normative Letter Number 19-0116-Amended related to Medications for Hepatitis C.
- Communication regarding Normative Letter Number 19-0116-Amended related to Medications for Hepatitis C.
- Communication regarding Normative Letter Number 19-0319 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0319 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0319 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0319 related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 19-0228, related to Second Extension of the Vital Government Health Plan Transition Period
- Communication regarding Normative Letter Number 19-0228, related to Second Extension of the Vital Government Health Plan Transition Period
- Communication regarding Normative Letter Number 19-0228, related to Second Extension of the Vital Government Health Plan Transition Period
- Communication regarding Normative Letter Number 19-0228, related to Second Extension of the Vital Government Health Plan Transition Period
- Communication regarding Normative Letter Number 19-0215, related to Oral Exam Certificate
- Communication regarding Normative Letter Number 19-0215, related to Oral Exam Certificate
- Communication regarding Normative Letter Number 19-0215, related to Oral Exam Certificate
- Communication regarding Normative Letter Number 19-0215, related to Oral Exam Certificate
- Communication regarding Normative Letter Number 19-0130, related to extension of the Transitional Period to Vital Plan
- Communication regarding Normative Letter Number 19-0130, related to extension of the Transitional Period to Vital Plan
- Communication regarding Normative Letter Number 19-0130, related to extension of the Transitional Period to Vital Plan
- Communication regarding Normative Letter Number 19-0130, related to extension of the Transitional Period to Vital Plan
- Communication regarding Normative Letter Number 2019-01-18, related to Physical and Behavioral Integrated Model
- Communication regarding Normative Letter Number 2019-01-18, related to Physical and Behavioral Integrated Model
- Communication regarding Normative Letter Number 2019-01-18, related to Physical and Behavioral Integrated Model
- Communication regarding Normative Letter Number 2019-01-18, related to Physical and Behavioral Integrated Model
- Communication regarding Providers Orientation
- Communication regarding Providers Orientation
- Communication regarding Providers Orientation
- Communication regarding Providers Orientation
- Notice of Privacy Practices
- Communication from Puerto Rico Health Insurance Administration October 5, 2018
- Communication from Puerto Rico Health Insurance Administration October 5, 2018
- Communication from Puerto Rico Health Insurance Administration October 5, 2018
- Communication from Puerto Rico Health Insurance Administration October 5, 2018
- Normative Letter 18-1003 Ammended from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 Ammended from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 Ammended from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 Ammended from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Informative Letter for the General Provider Network related to Plan Vital
- Informative Letter for the General Provider Network related to Plan Vital
- Informative Letter for the General Provider Network related to Plan Vital
- Informative Letter for the General Provider Network related to Plan Vital
- Informative Letter Dental Services Plan Vital
- Informative Letter Dental Services Plan Vital
- Informative Letter Dental Services Plan Vital
- Informative Letter Dental Services Plan Vital
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication related to Plan Vital Referral Form
- Communication regarding Normative Letter Number 18-10-02, related to Changes in the Covered Drug Formulary.
- Communication regarding Normative Letter Number 18-10-02, related to Changes in the Covered Drug Formulary.
- Communication regarding Normative Letter Number 18-10-02, related to Changes in the Covered Drug Formulary.
- Communication regarding Normative Letter Number 18-10-02, related to Changes in the Covered Drug Formulary.
- Communication regarding Normative Letter Number 18-1102, related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 18-1102, related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 18-1102, related to Changes in the Covered Drug Formulary
- Communication regarding Normative Letter Number 18-1102, related to Changes in the Covered Drug Formulary
- Normative Letter 18-1003 from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Normative Letter 18-1003 from Puerto Rico Health Insurance Administration related to Transition Period to Vital Plan
- Preventive Services Guidelines 2018
- Preventive Services Guidelines 2018
- Preventive Services Guidelines 2018
- Preventive Services Guidelines 2018
- Clinical Practice Guidelines
- Clinical Practice Guidelines
- Clinical Practice Guidelines
- Clinical Practice Guidelines
- Aviso sobre los Derechos Civiles de los Consumidores
Your Primary Care Physician and other doctors
When you sign up with First Medical, you must choose a doctor or Primary Care Physician (PCP). This is the main person you will see for most of your health care. This includes checkups, treatment for colds and flu, health concerns, and health screenings. Your PCP can find and treat health problems early. He or she will have your medical records. Your PCP can see your whole health care picture. Your PCP keeps track of all of the care you get.
There are different types of doctors who are PCP’s, like:
- General Practitioners
- Family Physicians
- Pediatricians
- Gynecologists/Obstetricians
- Internists
You must choose a PCP for each insured member in your family. Your family members can have different PCP’s.
If you are a woman over age twelve (12), you can also choose a gynecologist to be your PCP. If you are pregnant, your PCP could be your obstetrician during your pregnancy. When your pregnancy ends you will go back to your regular doctor, but your gynecologist will still take care of your gynecological needs. You may choose a pediatrician or a family physician for your newborn or one will be chosen for you.
To choose your PCP, call First Medical at 1-844-347-7800; TTY/TDD users should call 1-844-347-7805. If you do not choose one, then one will be chosen for you.
A Primary Medical Group is a group of doctors that help arrange your health care services and work with First Medical to make sure you get the care you need. Your ID card shows the name of your PCP and your Primary Medical Group number.